PharmaResearch Co., Ltd. (KOSDAQ: 214450)

South Korea flag South Korea · Delayed Price · Currency is KRW
247,500
+2,500 (1.02%)
Jan 21, 2025, 11:59 AM KST
111.18%
Market Cap 2.57T
Revenue (ttm) 317.00B
Net Income (ttm) 88.76B
Shares Out 10.39M
EPS (ttm) 8,057.05
PE Ratio 30.66
Forward PE 20.60
Dividend 950.00 (0.39%)
Ex-Dividend Date Dec 27, 2023
Volume 61,662
Average Volume 129,117
Open 248,000
Previous Close 245,000
Day's Range 245,000 - 253,500
52-Week Range 86,800 - 273,500
Beta 0.51
RSI 47.98
Earnings Date Feb 7, 2025

About PharmaResearch

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults thro... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1993
Employees 409
Stock Exchange KOSDAQ
Ticker Symbol 214450
Full Company Profile

Financial Performance

In 2023, PharmaResearch's revenue was 261.01 billion, an increase of 34.02% compared to the previous year's 194.76 billion. Earnings were 76.55 billion, an increase of 88.66%.

Financial Statements

News

There is no news available yet.